Skip to main content
Premium Trial:

Request an Annual Quote

Intrexon Prices Public Offering Targeting $200M

NEW YORK (GenomeWeb) – Intrexon today priced a public offering of almost 4.9 million shares of its common stock aimed at raising $200 million in gross proceeds. 

The Germantown, Maryland-based synthetic biology firm is offering 4,878,049 shares of its stock at $41 per share. Proceeds from the offering will go toward general corporate purposes and strategic acquisitions or investments, it said. 

JMP Securities is the sole book-running manager while Stifel is the lead manager on the offering. Griffin Securities and Wunderlich Securities are the co-managers. Intrexon has granted the underwriters a 30-day option to purchase up to an additional 731,707 shares. 

In afternoon trading, Intrexon shares rose 8 percent on the New York Stock Exchange to $45.94.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.